Last update at 2025-03-27T13:30:00Z
Read This Before Judging John Wiley & Sons, Inc.'s (NYSE:WLY) ROE
Sat 08 Mar 25, 01:53 PMJohn Wiley & Sons Inc (WLY) Q3 2025 Earnings Call Highlights: Strong Research Growth and ...
Fri 07 Mar 25, 07:12 AMQ3 2025 John Wiley & Sons Inc Earnings Call
Fri 07 Mar 25, 06:59 AMWiley (NYSE:WLY) Beats Q4 Sales Targets
Thu 06 Mar 25, 10:11 PMResearch Growth and AI Licensing Drive Wiley’s Third Quarter 2025 Results
Thu 06 Mar 25, 12:30 PMWiley appoints Karen N. Madden, Ph.D., to its Board of Directors
Wed 05 Mar 25, 01:30 PMQ3 Earnings Roundup: John Wiley & Sons (NYSE:WLY) And The Rest Of The Media Segment
Fri 31 Jan 25, 09:05 AMBreakdown | 2023-04-30 | 2022-04-30 | 2021-04-30 | 2020-04-30 | 2019-04-30 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2023-04-30 | 2022-04-30 | 2021-04-30 | 2020-04-30 | 2019-04-30 |
Income before tax | 33.10M | 209.66M | 175.91M | -63.09200M | 212.95M |
Minority interest | - | - | - | - | - |
Net income | 17.23M | 148.31M | 148.26M | -74.28700M | 168.26M |
Selling general administrative | 1037.40M | 1079.59M | 1022.66M | 997.36M | 963.58M |
Selling and marketing expenses | - | - | - | - | - |
Gross profit | 1327.36M | 1382.27M | 1316.17M | 1240.46M | 1245.35M |
Reconciled depreciation | 213.25M | 215.17M | 200.19M | 175.13M | 161.16M |
Ebit | 208.96M | 219.28M | 185.51M | 194.05M | 238.21M |
Ebitda | 422.22M | 442.70M | 435.77M | 369.18M | 399.36M |
Depreciation and amortization | 213.25M | 223.43M | 250.26M | 175.13M | 161.16M |
Non operating income net other | 14.96M | 10.19M | - | - | - |
Operating income | 208.96M | 219.28M | 185.51M | 194.05M | 223.99M |
Other operating expenses | 1814.82M | 1865.08M | 1722.68M | 1650.82M | 1572.96M |
Interest expense | 37.74M | 19.80M | 18.38M | 24.96M | 16.12M |
Tax provision | 15.87M | 61.35M | 27.66M | 11.20M | 44.69M |
Interest income | - | - | - | 13.38M | 11.10M |
Net interest income | -37.74500M | -19.80200M | -18.38300M | -11.57800M | -5.02100M |
Extraordinary items | - | - | - | - | - |
Non recurring | 99.80M | - | - | - | - |
Other items | - | - | - | - | - |
Income tax expense | 15.87M | 61.35M | 27.66M | 11.20M | 44.69M |
Total revenue | 2019.90M | 2082.93M | 1941.50M | 1831.48M | 1800.07M |
Total operating expenses | 1122.28M | 1164.42M | 1097.35M | 1059.79M | 1018.24M |
Cost of revenue | 692.54M | 700.66M | 625.34M | 591.02M | 554.72M |
Total other income expense net | -175.86300M | -9.61500M | -9.59900M | -257.14100M | -9.13400M |
Discontinued operations | - | - | - | - | - |
Net income from continuing ops | 17.23M | 148.31M | 148.26M | -74.28700M | 168.26M |
Net income applicable to common shares | 17.23M | 148.31M | 148.26M | -74.28700M | 168.26M |
Preferred stock and other adjustments | - | - | - | - | - |
Breakdown | 2023-04-30 | 2022-04-30 | 2021-04-30 | 2020-04-30 | 2019-04-30 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2023-04-30 | 2022-04-30 | 2021-04-30 | 2020-04-30 | 2019-04-30 |
Total assets | 3108.81M | 3361.70M | 3446.44M | 3168.79M | 2937.00M |
Intangible assets | 854.79M | 931.43M | 1064.82M | 861.05M | 928.04M |
Earning assets | - | - | - | - | - |
Other current assets | 93.71M | 81.92M | 78.39M | 59.47M | 67.44M |
Total liab | 2063.78M | 2219.43M | 2355.15M | 2235.17M | 1755.65M |
Total stockholder equity | 1045.03M | 1142.27M | 1091.29M | 933.62M | 1181.35M |
Deferred long term liab | 144.04M | 180.06M | 61.62M | 65.14M | 71.37M |
Other current liab | 281.86M | 314.53M | 312.82M | 282.18M | 272.22M |
Common stock | 83.18M | 83.18M | 83.18M | 83.18M | 83.18M |
Capital stock | 83.18M | 83.18M | 83.18M | 83.18M | 83.18M |
Retained earnings | 1860.87M | 1921.16M | 1850.06M | 1780.13M | 1931.07M |
Other liab | 308.80M | 349.19M | 411.26M | 382.47M | 406.30M |
Good will | 1204.05M | 1302.14M | 1304.34M | 1116.79M | 1095.67M |
Other assets | 168.94M | 193.97M | 196.80M | 188.95M | 195.96M |
Cash | 106.71M | 100.40M | 93.80M | 202.46M | 92.89M |
Cash and equivalents | - | - | - | - | - |
Total current liabilities | 895.55M | 969.42M | 988.97M | 927.27M | 870.56M |
Current deferred revenue | 504.69M | 538.13M | 545.42M | 520.21M | 507.37M |
Net debt | 776.79M | 839.75M | 896.07M | 754.15M | 385.90M |
Short term debt | 24.67M | 39.33M | 34.94M | 31.18M | - |
Short long term debt | 5.00M | 18.75M | 12.50M | 9.38M | - |
Short long term debt total | 883.50M | 940.14M | 989.86M | 956.62M | 478.79M |
Other stockholder equity | -370.12500M | -353.92700M | -351.15900M | -354.19000M | -324.17100M |
Property plant equipment | 247.15M | 383.29M | 200.90M | 233.22M | 88.82M |
Total current assets | 541.28M | 550.87M | 526.30M | 614.93M | 490.78M |
Long term investments | - | - | - | - | - |
Net tangible assets | 1045.03M | -1091.30200M | -1431.15100M | -1198.07100M | -980.09100M |
Short term investments | - | - | - | - | - |
Net receivables | 310.12M | 331.96M | 311.57M | 309.38M | 294.87M |
Long term debt | 743.29M | 768.28M | 809.09M | 765.65M | 478.79M |
Inventory | 30.73M | 36.59M | 42.54M | 43.61M | 35.58M |
Accounts payable | 84.33M | 77.44M | 95.79M | 93.69M | 90.98M |
Total permanent equity | - | - | - | - | - |
Noncontrolling interest in consolidated entity | - | - | - | - | - |
Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
Accumulated other comprehensive income | -528.90200M | -508.14600M | -490.79000M | -575.49700M | -508.73800M |
Additional paid in capital | - | - | - | - | - |
Common stock total equity | 83.18M | 83.18M | - | - | - |
Preferred stock total equity | - | - | - | - | - |
Retained earnings total equity | 1860.87M | 1921.16M | - | - | - |
Treasury stock | -839.92700M | -813.22400M | - | - | - |
Accumulated amortization | - | - | - | - | - |
Non currrent assets other | 170.34M | 193.97M | 147.28M | 135.31M | 97.31M |
Deferred long term asset charges | - | - | - | - | - |
Non current assets total | 2567.53M | 2810.83M | 2920.14M | 2553.87M | 2446.22M |
Capital lease obligations | 135.21M | 153.12M | 168.27M | 181.59M | - |
Long term debt total | - | - | - | - | - |
Breakdown | 2023-04-30 | 2022-04-30 | 2021-04-30 | 2020-04-30 | 2019-04-30 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2023-04-30 | 2022-04-30 | 2021-04-30 | 2020-04-30 | 2019-04-30 |
Investments | -98.39800M | -194.02400M | -433.15400M | -346.67000M | -301.50200M |
Change to liabilities | -121.37100M | -66.11600M | -5.94600M | 1.04M | 37.27M |
Total cashflows from investing activities | -98.39800M | -194.02400M | -433.15400M | -346.67000M | -301.50200M |
Net borrowings | -48.26800M | -10.99600M | 49.05M | 303.72M | 114.40M |
Total cash from financing activities | -168.56800M | -131.63800M | -47.08600M | 172.68M | -17.59500M |
Change to operating activities | -151.24800M | -104.42900M | -81.09100M | -71.95000M | -86.11700M |
Net income | 17.23M | 148.31M | 148.26M | -74.28700M | 168.26M |
Change in cash | 6.54M | 6.37M | -108.68800M | 109.50M | -76.70900M |
Begin period cash flow | 100.73M | 94.36M | 203.05M | 93.55M | 170.26M |
End period cash flow | 107.26M | 100.73M | 94.36M | 203.05M | 93.55M |
Total cash from operating activities | 277.07M | 339.10M | 359.92M | 288.44M | 250.83M |
Issuance of capital stock | - | - | - | - | - |
Depreciation | 213.25M | 215.17M | 200.19M | 175.13M | 161.16M |
Other cashflows from investing activities | -17.24300M | -105.18100M | - | - | - |
Dividends paid | -77.29800M | -77.20500M | -76.93800M | -76.65800M | 75.75M |
Change to inventory | -0.52200M | 2.31M | 7.84M | -2.71400M | 3.82M |
Change to account receivables | 26.76M | -26.31800M | -7.26300M | -2.96200M | -52.93900M |
Sale purchase of stock | -35.00000M | -30.00000M | -15.76500M | -46.58900M | -59.99400M |
Other cashflows from financing activities | -17.33600M | 637.44M | 14.96M | -7.84800M | -1.92300M |
Change to netincome | 146.05M | 80.05M | 111.38M | 270.14M | 21.56M |
Capital expenditures | 106.69M | 121.70M | 133.21M | 90.43M | 86.66M |
Change receivables | 26.76M | -26.31800M | - | - | - |
Cash flows other operating | 28.04M | 19.43M | - | - | - |
Exchange rate changes | - | - | - | - | - |
Cash and cash equivalents changes | 10.11M | 13.44M | - | - | - |
Change in working capital | -138.63400M | -104.42900M | -99.90400M | -80.44400M | -98.52600M |
Stock based compensation | 26.50M | 25.70M | 21.98M | 20.01M | 18.33M |
Other non cash items | 185.22M | 54.34M | 111.38M | 65.69M | 19.94M |
Free cash flow | 170.38M | 217.40M | 226.71M | 198.00M | 164.17M |
Sector: Communication Services Industry: Publishing
Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
---|---|---|---|---|---|---|---|---|
WLYB John Wiley & Sons B |
- -% | 44.80 | - | 10.80 | 0.93 | 2.07 | 1.43 | 24.94 |
IFJPY Informa PLC ADR |
0.05 0.24% | 21.12 | 31.68 | 15.17 | 4.86 | 1.52 | 5.28 | 16.64 |
IFPJF Informa plc |
- -% | 10.44 | 30.13 | 13.62 | 5.38 | 1.37 | 5.30 | 16.72 |
PSO Pearson PLC ADR |
0.02 0.13% | 15.97 | 24.14 | 13.77 | 2.16 | 1.58 | 2.48 | 9.25 |
NYT New York Times Company |
-0.13 0.27% | 48.85 | 39.65 | 28.09 | 3.15 | 4.55 | 3.00 | 20.53 |
John Wiley & Sons, Inc. operates as a research and education company worldwide. The company operates through three segments: Research, Academic, and Talent. The company offers scientific, technical, medical, and scholarly journals, as well as related content and services to learned societies, individual researchers, other professionals, and academic, corporate, and government libraries. It publishes physical sciences and engineering, health sciences, social sciences, and humanities and life sciences journals; and provides a publishing software and service for scholarly and professional societies, and publishers to deliver, host, enhance, market, and manage their content on the web through the Literatum platform. In addition, it sells and distributes its products through various channels, including research libraries and library consortia, and independent subscription agents, as well as directly to professional society members, bookstores, online booksellers, and other customers. Further, it provides education publishing and professional learning products and services, including scientific, professional, and education print and digital books, digital courseware, and test preparation services to libraries, corporations, students, professionals, and researchers. Furthermore, it distributes its products through chain and online booksellers, libraries, colleges and universities, corporations, direct to consumer, websites, distributor networks, and other online applications; and offers talent development for professionals and businesses, assessments, and corporate learning. John Wiley & Sons, Inc. was founded in 1807 and is headquartered in Hoboken, New Jersey.
111 River Street, Hoboken, NJ, United States, 07030-5774
Name | Title | Year Born |
---|---|---|
Mr. Jesse Caleb Wiley | Non-Exec. Chairman | 1971 |
Mr. Brian A. Napack | Pres, CEO & Director | 1962 |
Ms. Christina M. Van Tassell | Exec. VP & CFO | 1971 |
Mr. Aref Matin | Exec. VP & CTO | 1959 |
Mr. Todd R. Zipper | Exec. VP & GM of Education Services | 1977 |
Mr. Matthew Leavy | Exec. VP & GM of Academic and Professional Learning | 1968 |
Ms. Danielle McMahan | Exec. VP and Chief People & Operations Officer | 1975 |
Mr. Christopher F. Caridi | Sr. VP, Chief Accounting Officer & Global Corp. Controller | 1967 |
Mr. Brian Campbell | VP, Investor Relations | NA |
Ms. Deirdre P. Silver | Exec. VP, Gen. Counsel & Sec. | 1968 |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.